Switching between cyclosporin formulations. What are the risks?
- 1 June 1997
- journal article
- case report
- Published by Springer Nature in Drug Safety
- Vol. 16 (6) , 366-373
- https://doi.org/10.2165/00002018-199716060-00003
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- VARIABLE ORAL ABSORPTION OF CYCLOSPORINETransplantation, 1996
- The Use of Therapeutic Drug Monitoring to Optimise Immunosuppressive TherapyClinical Pharmacokinetics, 1996
- CyclosporinDrugs, 1995
- Within-Day Consistency in Cyclosporine Pharmacokinetics from a Microemulsion Formulation in Renal Transplant PatientsTherapeutic Drug Monitoring, 1994
- Prevention and Management of the Adverse Effects Associated with Immunosuppressive TherapyDrug Safety, 1993
- Cyclosporin Clinical PharmacokineticsClinical Pharmacokinetics, 1993
- Pharmacodynamic Monitoring of CyclosporinClinical Pharmacokinetics, 1992
- Small-Bowel Length and the Dose of Cyclosporine in Children after Liver TransplantationNew England Journal of Medicine, 1990
- CyclosporineNew England Journal of Medicine, 1989
- OPTIMIZATION OF CYCLOSPORINE THERAPY IN RENAL TRANSPLANTATION BY A PHARMACOKINETIC STRATEGYTransplantation, 1988